"10.1371_journal.pone.0009001","plos one","2010-02-02T00:00:00Z","Paul W Hollenbach; Aaron N Nguyen; Helen Brady; Michelle Williams; Yuhong Ning; Normand Richard; Leslie Krushel; Sharon L Aukerman; Carla Heise; Kyle J MacBeth","Celgene Corporation, San Francisco, California, United States of America; Department of Biochemistry and Molecular Genetics, University of Colorado Denver School of Medicine, Aurora, Colorado, United States of America","Conceived and designed the experiments: PWH ANN LK SLA CH KJM. Performed the experiments: PWH ANN HB MW NR. Analyzed the data: PWH ANN HB MW YN NR LK SLA CH KJM. Wrote the paper: PWH ANN KJM. Interpretation of data: PWH ANN HB MW YN NR LK SLA CH KJM. Critical review of manuscript content: PWH ANN HB MW YN NR LK SLA CH KJM.","Vidaza is a marketed product with azacitidine as the active pharmaceutical ingredient. Dacogen is a marketed product with decitabine as the active pharmaceutical ingredient. The authors are able to adhere to the PLoS ONE policies on sharing data and materials. P.W.H., A.N.N., H.B., Y.N., N.R., S.L.A., C.H., and K.J.M. are employees of Celgene and as such own stock in the company. M.W. and L.K. received research support from Celgene.","2010","02","Paul W Hollenbach","PWH",10,TRUE,6,5,10,3,TRUE,TRUE,FALSE,0,NA,FALSE
